InvestSMART

Immutep Limited (ASX: IMM) - Announcements

Current share price for IMM : $0.023 0.001 (4.17%)+

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Immutep completes underwritten retail entitlement offer 27 Jun 2023 8:16AM $0.280 $0.023 fallen by 91.79%
$34 Immutep granted US patent for IMP761 agonist LAG-3 antibody 20 Jun 2023 2:43PM $0.300 $0.023 fallen by 92.33%
$34 Change in substantial holding from IFL 16 Jun 2023 4:53PM $0.300 $0.023 fallen by 92.33%
$34 Change in substantial holding 13 Jun 2023 6:47PM $0.295 $0.023 fallen by 92.20%
$34 Change in substantial holding 13 Jun 2023 8:10AM $0.290 $0.023 fallen by 92.07%
$34 Becoming a substantial holder 9 Jun 2023 2:58PM $0.285 $0.023 fallen by 91.93%
$34 Cleansing Notice 8 Jun 2023 10:51AM $0.300 $0.023 fallen by 92.33%
$34 Application for quotation of securities - IMM 8 Jun 2023 10:20AM $0.305 $0.023 fallen by 92.46%
$34 Immutep letter to ineligible shareholders 6 Jun 2023 8:36AM $0.305 $0.023 fallen by 92.46%
$34 Immutep retail entitlement offer booklet 6 Jun 2023 8:13AM $0.305 $0.023 fallen by 92.46%
$34 Positive final data in 2nd line head and neck cancer at ASCO 5 Jun 2023 8:41AM $0.260 $0.023 fallen by 91.15%
$34 Immutep completes institutional pro-rata offer & placement 2 Jun 2023 9:02AM $0.300 $0.023 fallen by 92.33%
$34 Change in substantial holding 1 Jun 2023 8:22AM $0.300 $0.023 fallen by 92.33%
$34 Cleansing Notice 31 May 2023 10:47AM $0.300 $0.023 fallen by 92.33%
$34 Proposed issue of securities - IMM 31 May 2023 10:25AM $0.300 $0.023 fallen by 92.33%
$34 Immutep Capital Raising Presentation 31 May 2023 10:10AM $0.300 $0.023 fallen by 92.33%
$34 A$80 million fully underwritten equity raising 31 May 2023 9:38AM $0.300 $0.023 fallen by 92.33%
$34 Trading Halt 31 May 2023 9:21AM $0.300 $0.023 fallen by 92.33%
$34 Charles River Laboratories to run IMP761 Toxicology Study 29 May 2023 8:20AM $0.315 $0.023 fallen by 92.70%
$34 Publication of Abstracts for ASCO 2023 Annual Meeting 26 May 2023 8:24AM $0.370 $0.023 fallen by 93.78%
$34 1st patient dosed in AIPAC-003 ph2/3 breast cancer trial 25 May 2023 8:19AM $0.355 $0.023 fallen by 93.52%
$34 Promising New Data in 1st line NSCLC from INSIGHT-003 Trial 24 May 2023 9:01AM $0.330 $0.023 fallen by 93.03%
$34 Excellent initial Overall Survival Benefit in 1st line NSCLC 17 May 2023 9:02AM $0.235 $0.023 fallen by 90.21%
$34 FDA supportive of Efti registrational trial in lung cancer 16 May 2023 8:18AM $0.225 $0.023 fallen by 89.78%
$34 Change of Director's Interest Notice - R Howard 2 May 2023 8:18AM $0.260 $0.023 fallen by 91.15%

276 - 300 of 798 results

Page 12 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.